Bone Regeneration Using PRF After Cyst Enucleation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSana'a University
About this trial
This randomized controlled clinical trial aims to evaluate the clinical efficacy of autologous platelet-rich fibrin (PRF) in promoting osseous regeneration following cystic enucleation in the jaws. The study will assess bone healing outcomes and compare PRF application with conventional management methods.
Eligibility criteria
Qualifiers
Patients diagnosed with odontogenic cysts requiring surgical enucleation.
Presence of a postoperative osseous defect in the jaws after cyst enucleation.
Age ≥ 18 years.
Systemically healthy patients (ASA I or II).
Disqualifiers
Patients with systemic diseases affecting bone healing (e.g., uncontrolled diabetes, osteoporosis).
Patients receiving bisphosphonates or long-term corticosteroid therapy.
Smokers (>10 cigarettes/day).
Pregnant or lactating women.
Trial design
Treatments tested in this trial
- Autologous Platelet-Rich Fibrin (PRF)
- Conventional Surgical Management
Treatment groups
20 Participants
are divided into 2 treatment groupsLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Faculty of Medicine and Health Sciences - Sana'a UniversityRecruiting00000, Sanaa, Sanaa Governorate
Yemen
YemenSponsors and collaborators
Source ClinicalTrials.gov